Electromed (ELMD) Stock: Buy, Sell, or Hold?
ELMD - Electromed, Inc.
$27.25
0.60 (2.25%)
▲
5d:
-1.3%
30d:
-35.85%
90d:
-27.55%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 25, 2026
0d
Get Alerted When ELMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ELMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ELMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$63.03
Based on 12.8% avg growth
INTRINSIC VALUE TODAY
$39.14
30.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELMD is currently trading at $27.25, which is considered oversold relative to its 30-day fair value range of $29.12 to $42.31. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.4) compared to its historical average (23.5). Remarkably, the market is currently pricing in an annual earnings decline of 7.8% over the next few years. This pessimistic expectation contrasts with the company's recent 49.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ELMD is in a uptrend. The price is currently testing key support at $26.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $48.50 (+78.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ELMD is in a uptrend. The price is currently testing key support at $26.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $48.50 (+78.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$29.12 -
$42.31
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.5%
Protect Your Profits
Holding ELMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 78.0% below Wall St target ($48.50)
- NEUTRAL: Bottoming setup forming (45/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$29.12 -
$42.31
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$2.29
(8.4%)
Support & Resistance Levels
Support Level
$26.62
Resistance Level
$30.66
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.41
Wall Street Target
$48.50
(+78.0%)
Revenue Growth (YoY)
11.6%
Earnings Growth (YoY)
49.0%
Profit Margin
15.3%
Valuation Discount vs History
-7.8% cheaper
PE vs Historical
18.4 vs 23.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.8%
(market-implied from PE analysis)
1-Year Target
$25.12
(-8%)
2-Year Target
$23.16
(-15%)
3-Year Target
$21.36
(-22%)
3-Yr Target (if PE normalizes)
(PE: 18→24)
$27.26
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 21.6%)
$53.73
(+97%)
Base:
(SPY PE: 18.4, Growth: 21.6%)
$49.05
(+80%)
Bear:
(PE: 15.7, Growth: 21.6%)
$41.69
(+53%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 20.82 | Current EPS (TTM): $1.28
Bull Case
$33.90
(+24%)
Analyst growth 15.6%, PE expands to 22.9
Base Case
$30.81
(+13%)
Market implied 15.6%, PE stable at 20.8
Bear Case
$18.12
(-34%)
Severe decline -20.0%, PE contracts to 17.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.4 to 23.5
Stabilization Target:
$34.78
(+27.6%)
PE Expansion Potential:
+27.6%
Share & Embed Analysis
Last updated: September 12, 2026 10:24 PM ET
Data refreshes hourly during market hours. Next update: 11:24 PM
Data refreshes hourly during market hours. Next update: 11:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
Advanced ELMD Option Strategies
Professional options setups generated by AI based on today's ELMD price and gamma walls.
